AAAAI VJC logo

AAAAI-NAIA/JACI: In Practice Virtual Journal Club: May 27, 2020

May 27, 2020

The Virtual Journal Club is a one hour live webinar open to all AAAAI members that will focus on the newest clinically relevant content published in JACI: In Practice. The presenters will review research relevant to your allergy/immunology practice in an interactive format.

The May 27, 2020 webinar will focus on two journal articles as follows (click the Program tab to download the PDFs):

Children Monosensitized to Can f 5 Show Different Reactions to Male and Female Dog Allergen Extract Provocation: A
Randomized Controlled Trial

Discussion Leader: Amy Schiffman, MD

Mentor: Thomas A. E. Platts-Mills, MD PhD FAAAAI

Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone
Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy

Discussion Leader: Stephanie Leeds, MD FAAAAI

Mentor: Matthew Rank, MD FAAAAI


 

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize the relationship between sensitization to dog dander allergen components and clinical reactivity to male versus female dogs
  • Identify the differences in effectiveness and safety in patients with controlled asthma who maintain inhaled corticosteroid (ICS)/Long-acting beta agonist (LABA) therapy compared to those who step down to ICS monotherapy.
Summary
Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.
Course opens: 
04/29/2020
Course expires: 
12/31/2020
Event starts: 
05/27/2020 - 7:30pm
Event ends: 
05/27/2020 - 8:35pm
Cost:
$0.00
Rating: 
0
Schoos A-M, et al. Children Monosensitized to Can f 5 Show Different Reactions to Male and Female Dog Allergen Extract Provocation: A
Randomized Controlled Trial.
J Allergy Clin Immunol Pract 2020; In Press.

Male and Female Dog Allergy Extract Provocation.pdf


Weinstein C, et al. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy. J Allergy Clin Immunol Pract 2019.

Serious Asthma Outcomes - Combination Compared to Step Down Monotherapy.pdf

 

 

Planning Committee

Benjamin Prince, MD MCSI FAAAAI
Nationwide Children's Hospital, Columbus, OH
Relevant relationships: None

Ashwini Reddy, MD
Children's Hospital of Philadephia/University of Pennsylvania, Philadelphia, PA
Relevant relationships: None

Michael Schatz, MD MS FAAAAI
Kaiser Permanente Medical Center, San Diego, CA
Relevant relationships: None

Maria Slack, MD
Blanchard Valley Hospital, Findlay, OH
Relevant relationships: None

Jonathan Tam, MD
Children's Hospital Los Angeles, Los Angeles, CA
Relevant relationships: None


Faculty

Stephanie Leeds, MD FAAAAI
Yale University, Greenwich, CT
Relevant relationships: None

Thomas A.E. Platts-Mills, MD PhD FAAAAI
University of Virginia, Charlottesville, VA
Relevant relationships: None

Benjamin Prince, MD MCSI FAAAAI
Nationwide Children's Hospital, Columbus, OH
Relevant relationships: None

Matthew Rank, MD FAAAAI
Stanford, University, Woodside, CA
Relevant relationships: None

Amy Schiffman, MD
Allergy, Asthma, & Immunology Specialists, LLC, Boca Raton, FL
Relevant relationships: None


Content Reviewer

Lois Nelson, MD FAAAAI
University of Toledo, Toledo, OH
Relevant relationships: None


AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on December 31, 2020. Requests to claim credit on or after January 1, 2021 will be subject to an administrative fee.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org

Questions

Activity-related questions should be directed to Rebecca Brandt at rbrandt@aaaai.org.

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.